Programs & Impact

COVID-19 vaccine effectiveness
AFOM supports a large-scale COVID-19 vaccine effectiveness study in Zimbabwe, tracking over 6,000 participants. The research provides critical data to inform global vaccine policy and highlights the importance of African-led science in shaping pandemic responses.

HIV Study
Through Mutala Trust, AFOM is advancing HIV vaccine research by supporting clinical trials and immunology capacity-building. These efforts aim to close gaps in HIV prevention and ensure African populations are represented in the development of future vaccines.

Maternal health
AFOM supports research focused on pregnancy complications, neonatal outcomes, and pediatric health. These studies aim to improve maternal and child health across Africa by generating evidence for better care and interventions.

NCDs
AFOM is expanding research into NCDs such as cardiovascular disease, diabetes, and cancer—conditions increasingly affecting African communities. By funding studies and infrastructure, AFOM helps build long-term capacity to address these growing health challenges.
